Capital Senior Living Corp (CSU) Fundamental Analysis & Valuation

NYSE:CSU

Current stock price

33.54
-0.72 (-2.09%)
Last:

This CSU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CSU Profitability Analysis

1.1 Basic Checks

  • CSU had negative earnings in the past year.
CSU Yearly Net Income VS EBIT VS OCF VS FCFCSU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -21.75%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSU Yearly ROA, ROE, ROICCSU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 100 -100 -200

1.3 Margins

  • CSU does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -49.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSU Yearly Profit, Operating, Gross MarginsCSU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CSU Health Analysis

2.1 Basic Checks

  • CSU has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, CSU has a worse debt to assets ratio.
CSU Yearly Shares OutstandingCSU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 500K 1M 1.5M 2M
CSU Yearly Total Debt VS Total AssetsCSU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -1.29, we must say that CSU is in the distress zone and has some risk of bankruptcy.
  • CSU has a Debt/Equity ratio of -2.98. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -2.98
Debt/FCF N/A
Altman-Z -1.29
ROIC/WACCN/A
WACCN/A
CSU Yearly LT Debt VS Equity VS FCFCSU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 0.11 indicates that CSU may have some problems paying its short term obligations.
  • A Quick Ratio of 0.11 indicates that CSU may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
CSU Yearly Current Assets VS Current LiabilitesCSU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CSU Growth Analysis

3.1 Past

  • CSU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -169.26%.
  • Looking at the last year, CSU shows a very negative growth in Revenue. The Revenue has decreased by -30.87% in the last year.
  • CSU shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.41% yearly.
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%

3.2 Future

  • CSU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.95% yearly.
  • CSU is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.59% yearly.
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CSU Yearly Revenue VS EstimatesCSU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CSU Yearly EPS VS EstimatesCSU Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. CSU Valuation Analysis

4.1 Price/Earnings Ratio

  • CSU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSU Price Earnings VS Forward Price EarningsCSU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.81
CSU Per share dataCSU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CSU's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.76%
EPS Next 3Y25.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CSU Dividend Analysis

5.1 Amount

  • CSU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CSU Fundamentals: All Metrics, Ratios and Statistics

Capital Senior Living Corp

NYSE:CSU (11/12/2021, 8:52:54 PM)

33.54

-0.72 (-2.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners127.24%
Ins Owner Change0%
Market Cap70.07M
Revenue(TTM)295.44M
Net Income(TTM)-147.62M
Analysts42.5
Price Target23.46 (-30.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 38.81
EPS(TTM)-72.7
EYN/A
EPS(NY)-5.77
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS141.43
BVpS-91.27
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -49.97%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity -2.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -1.29
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Capital Senior Living Corp / CSU Fundamental Analysis FAQ

What is the fundamental rating for CSU stock?

ChartMill assigns a fundamental rating of 1 / 10 to CSU.


What is the valuation status of Capital Senior Living Corp (CSU) stock?

ChartMill assigns a valuation rating of 0 / 10 to Capital Senior Living Corp (CSU). This can be considered as Overvalued.


Can you provide the profitability details for Capital Senior Living Corp?

Capital Senior Living Corp (CSU) has a profitability rating of 1 / 10.


Can you provide the financial health for CSU stock?

The financial health rating of Capital Senior Living Corp (CSU) is 2 / 10.